FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2146349807> ?p ?o ?g. }

• W2146349807 abstract "OPtimizing Transdermal Exelon In Mild-to-moderate Alzheimer’s disease (OPTIMA) was a randomized, double-blind comparison of 13.3 mg/24 h versus 9.5 mg/24 h rivastigmine patch in patients with mild-to-moderate Alzheimer’s disease who declined despite open-label treatment with 9.5 mg/24 h patch. Over 48 weeks of double-blind treatment, high-dose patch produced greater functional and cognitive benefits compared with 9.5 mg/24 h patch. Using OPTIMA data, a post-hoc responder analysis was performed to firstly, compare the proportion of patients demonstrating improvement or absence of decline with 13.3 mg/24 h versus 9.5 mg/24 h patch; and secondly, identify predictors of improvement or absence of decline. ‘Improvers’ were patients who improved on the Alzheimer’s Disease Assessment Scale–cognitive subscale (ADAS-cog) by ≥4 points from baseline, and did not decline on the instrumental domain of the Alzheimer’s Disease Cooperative Study–Activities of Daily Living scale (ADCS-IADL). ‘Non-decliners’ were patients who did not decline on either scale. Overall, 265 patients randomized to 13.3 mg/24 h and 271 to 9.5 mg/24 h patch met the criteria for inclusion in the intention-to-treat population and were included in the analyses. Significantly more patients were ‘improvers’ with 13.3 mg/24 h compared with 9.5 mg/24 h patch at Weeks 24 (44 (16.6%) versus 19 (7.0%); P < 0.001) and 48 (21 (7.9%) versus 10 (3.7%); P = 0.023). A significantly greater proportion of patients were ‘non-decliners’ with 13.3 mg/24 h compared with 9.5 mg/24 h patch at Week 24 (71 (26.8%) versus 44 (16.2%); P = 0.002). At Week 48, there was a trend in favor of 13.3 mg/24 h patch. Functional and cognitive assessment scores at double-blind baseline did not consistently predict effects at Weeks 24 or 48. More patients with mild-to-moderate Alzheimer’s disease who are titrated to 13.3 mg/24 h rivastigmine patch at time of decline are ‘improvers’ or ‘non-decliners’ i.e. show responses on cognition and activities of daily living compared with patients remaining on 9.5 mg/24 h patch. Clinicaltrials.gov identifier: NCT00506415 ; registered July 20, 2007." @default.
• W2146349807 created "2016-06-24" @default.
• W2146349807 creator A5000771869 @default.
• W2146349807 creator A5008190526 @default.
• W2146349807 creator A5024952302 @default.
• W2146349807 creator A5050497539 @default.
• W2146349807 creator A5060487287 @default.
• W2146349807 creator A5084326649 @default.
• W2146349807 creator A5084898631 @default.
• W2146349807 date "2015-03-08" @default.
• W2146349807 modified "2023-10-10" @default.
• W2146349807 title "Responder analysis of a randomized comparison of the 13.3 mg/24 h and 9.5 mg/24 h rivastigmine patch" @default.
• W2146349807 cites W1479810593 @default.
• W2146349807 cites W1847168837 @default.
• W2146349807 cites W1953027527 @default.
• W2146349807 cites W1964659961 @default.
• W2146349807 cites W1987699981 @default.
• W2146349807 cites W1995637924 @default.
• W2146349807 cites W1996776294 @default.
• W2146349807 cites W2008759843 @default.
• W2146349807 cites W2008854521 @default.
• W2146349807 cites W2016981346 @default.
• W2146349807 cites W2058161128 @default.
• W2146349807 cites W2064549315 @default.
• W2146349807 cites W2086240173 @default.
• W2146349807 cites W2087534268 @default.
• W2146349807 cites W2100653952 @default.
• W2146349807 cites W2135812251 @default.
• W2146349807 cites W2144352416 @default.
• W2146349807 cites W2148080316 @default.
• W2146349807 cites W2156220037 @default.
• W2146349807 cites W2167311298 @default.
• W2146349807 cites W2193764494 @default.
• W2146349807 cites W2440881702 @default.
• W2146349807 cites W54082376 @default.
• W2146349807 doi "https://doi.org/10.1186/s13195-014-0088-8" @default.
• W2146349807 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4353453" @default.
• W2146349807 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25755685" @default.
• W2146349807 hasPublicationYear "2015" @default.
• W2146349807 type Work @default.
• W2146349807 sameAs 2146349807 @default.
• W2146349807 citedByCount "8" @default.
• W2146349807 countsByYear W21463498072015 @default.
• W2146349807 countsByYear W21463498072016 @default.
• W2146349807 countsByYear W21463498072018 @default.
• W2146349807 countsByYear W21463498072021 @default.
• W2146349807 countsByYear W21463498072022 @default.
• W2146349807 countsByYear W21463498072023 @default.
• W2146349807 crossrefType "journal-article" @default.
• W2146349807 hasAuthorship W2146349807A5000771869 @default.
• W2146349807 hasAuthorship W2146349807A5008190526 @default.
• W2146349807 hasAuthorship W2146349807A5024952302 @default.
• W2146349807 hasAuthorship W2146349807A5050497539 @default.
• W2146349807 hasAuthorship W2146349807A5060487287 @default.
• W2146349807 hasAuthorship W2146349807A5084326649 @default.
• W2146349807 hasAuthorship W2146349807A5084898631 @default.
• W2146349807 hasBestOaLocation W21463498071 @default.
• W2146349807 hasConcept C126322002 @default.
• W2146349807 hasConcept C168563851 @default.
• W2146349807 hasConcept C205679159 @default.
• W2146349807 hasConcept C2775842315 @default.
• W2146349807 hasConcept C2776332859 @default.
• W2146349807 hasConcept C2779134260 @default.
• W2146349807 hasConcept C2779483572 @default.
• W2146349807 hasConcept C2780904820 @default.
• W2146349807 hasConcept C2908647359 @default.
• W2146349807 hasConcept C2984863031 @default.
• W2146349807 hasConcept C71924100 @default.
• W2146349807 hasConcept C98274493 @default.
• W2146349807 hasConcept C99454951 @default.
• W2146349807 hasConceptScore W2146349807C126322002 @default.
• W2146349807 hasConceptScore W2146349807C168563851 @default.
• W2146349807 hasConceptScore W2146349807C205679159 @default.
• W2146349807 hasConceptScore W2146349807C2775842315 @default.
• W2146349807 hasConceptScore W2146349807C2776332859 @default.
• W2146349807 hasConceptScore W2146349807C2779134260 @default.
• W2146349807 hasConceptScore W2146349807C2779483572 @default.
• W2146349807 hasConceptScore W2146349807C2780904820 @default.
• W2146349807 hasConceptScore W2146349807C2908647359 @default.
• W2146349807 hasConceptScore W2146349807C2984863031 @default.
• W2146349807 hasConceptScore W2146349807C71924100 @default.
• W2146349807 hasConceptScore W2146349807C98274493 @default.
• W2146349807 hasConceptScore W2146349807C99454951 @default.
• W2146349807 hasIssue "1" @default.
• W2146349807 hasLocation W21463498071 @default.
• W2146349807 hasLocation W21463498072 @default.
• W2146349807 hasLocation W21463498073 @default.
• W2146349807 hasLocation W21463498074 @default.
• W2146349807 hasOpenAccess W2146349807 @default.
• W2146349807 hasPrimaryLocation W21463498071 @default.
• W2146349807 hasRelatedWork W1536512737 @default.
• W2146349807 hasRelatedWork W162134209 @default.
• W2146349807 hasRelatedWork W1751954123 @default.
• W2146349807 hasRelatedWork W1972516764 @default.
• W2146349807 hasRelatedWork W2042696917 @default.
• W2146349807 hasRelatedWork W2467334599 @default.
• W2146349807 hasRelatedWork W2765993423 @default.
• W2146349807 hasRelatedWork W3138811377 @default.
• W2146349807 hasRelatedWork W4230541412 @default.
• W2146349807 hasRelatedWork W3127387047 @default.

• next